Keyword: 340B Health

The administration has overstepped its boundaries, and patients will suffer under the rule, said AHA's president. Physician organizations disagree.

HHS is planning an about-face on the long-delayed rule that would set price ceilings and monetary penalties in the 340B program.

CEOs from more than 700 hospitals sent a letter to congressional leaders, calling on them to protect the 340B drug discount program.

As part of its ongoing efforts to protect the 340B program, the AHA unveiled a set of “stewardship principles” to boost transparency. 

Four national healthcare organizations have sued HHS over the long delay of its final rule that would implement price ceilings in the 340B program.

Some individuals were not aware they had become part of an organized campaign to oppose what’s known as the 340B program.

Several hospital groups refiled a lawsuit against the Department of Health and Human Services over cuts to the 340B drug discount program.

The drug industry continued its campaign to spread the blame for high prescription drug prices with its latest commissioned analysis.

Leaders of the House and Senate are asking HRSA to finalize 340B regulations that have been delayed multiple times.

Industry groups are weighing in on CMS' plans for site-neutral payments and changes to the 340B program.